Cost-Effectiveness model for rTMS versus Antidepressant

This is a cost effectiveness model for evaluating the cost effectiveness of rTMS versus pharmacotherapy for the treatment of patients with major depressive disorder who have failed at least two adequate courses of antidepressant medications. The model is developed in TreeAge pro suite and contains all the information required to generate the results presented in the paper "Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment Resistant Depression", published in Value in Health (2015)